SCHEMBL18155075

SCHEMBL18155075

CN(C)C1CCN(c2ccc3[nH]c(-c4cc(-c5cccc(CO)c5)c[nH]c4=O)nc3c2)CC1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFB2 P61812 1/20 0.66
PDGFRB P09619 2/20 0.40
FGFR1 P11362 2/20 0.40
KDR P35968 2/20 0.40
CDK1 P06493 3/20 0.38
CDK4 P11802 2/20 0.38
CCNB1 P14635 2/20 0.38
CCND1 P24385 2/20 0.38
CCND3 P30281 2/20 0.38
CDK6 Q00534 2/20 0.38
IGF1R P08069 1/20 0.38
CYP3A4 P08684 1/20 0.38
PARP1 P09874 2/20 0.35
BRD4 O60885 3/20 0.35
CDK2 P24941 2/20 0.35
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
PIK3CA P42336 1/20 0.35
MTOR P42345 1/20 0.35
MGLL Q99685 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL18155057 0.97 TGFB2 (0.63) TGFB2PDGFRBFGFR1KDRCDK1
SCHEMBL20048525 0.91 TGFB2 (0.71) TGFB2PDGFRBFGFR1KDRPARP1
SCHEMBL18155081 0.90 TGFB2 (0.70) TGFB2PDGFRBFGFR1KDRPARP1
Hydrochloric Acid SCHEMBL21456789 0.89 TGFB2 (0.69) TGFB2PDGFRBFGFR1KDRPARP1
SCHEMBL18164072 0.88 TGFB2 (0.71) TGFB2PDGFRBFGFR1KDRCDK4
SCHEMBL18155029 0.87 TGFB2 (0.87) TGFB2PDGFRBFGFR1KDRCDK1
SCHEMBL18155035 0.86 TGFB2 (0.74) TGFB2PDGFRBFGFR1KDRBRD4
Hydrochloric Acid SCHEMBL18155058 0.86 TGFB2 (0.85) TGFB2PDGFRBFGFR1KDRCDK1
SCHEMBL18155044 0.85 TGFB2 (0.67) TGFB2PDGFRBFGFR1KDRBRD4
SCHEMBL18155108 0.84 TGFB2 (0.81) TGFB2CDK1PARP1CDK2MKNK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3283475-B1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-10-16 EP claimed
EP-3283475-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES Merck Patent GmbH (DE) 2018-02-21 EP claimed
WO-2016165808-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2016-10-20 WO claimed
EP-3283475-B1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-10-16 EP disclosed
US-10179777-B2 3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives MERCK PATENT GMBH (DE) 2019-01-15 US disclosed
US-20180099947-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2018-04-12 US disclosed
WO-2016165808-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2016-10-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10179777-B2 3-(1H-benzimidazol-2-yl)-1H-pyridin-2-one derivatives ALK, ABL2, ACVR1 TGFB2 267/4885PDGFRB 42/4885FGFR1 26/4885
US-20180099947-A1 3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRIDIN-2-ONE DERIVATIVES ALK, ABL2, ACVR1 TGFB2 267/4885PDGFRB 42/4885FGFR1 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.